sulfamethizole has been researched along with Hyperkalemia in 1 studies
Sulfamethizole: A sulfathiazole antibacterial agent.
sulfamethizole : A sulfonamide consisting of a 1,3,4-thiadiazole nucleus with a methyl substituent at C-5 and a 4-aminobenzenesulfonamido group at C-2.
Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Trimethoprim therapy can cause hyperkalemia and is often coprescribed with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs)." | 7.76 | Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study. ( Antoniou, T; Glazier, RH; Gomes, T; Juurlink, DN; Loutfy, MR; Mamdani, MM, 2010) |
"Trimethoprim therapy can cause hyperkalemia and is often coprescribed with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs)." | 3.76 | Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study. ( Antoniou, T; Glazier, RH; Gomes, T; Juurlink, DN; Loutfy, MR; Mamdani, MM, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antoniou, T | 1 |
Gomes, T | 1 |
Juurlink, DN | 1 |
Loutfy, MR | 1 |
Glazier, RH | 1 |
Mamdani, MM | 1 |
1 other study available for sulfamethizole and Hyperkalemia
Article | Year |
---|---|
Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhi | 2010 |